InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,967.23
(
-0.88%
)
US TECH 100
16,554.00
(
-2.26%
)
Dow Jones
37,986.40
(
0.56%
)
Brent Oil
86.63
(
0.00%
)
Bitcoin
63,962.76
(
0.21%
)
Post# of 251544
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Bickema

Send PM Follow Ignore
Followers 20
Posts 1631
Boards Moderated 0
Alias Born 11/10/2010

Bickema

Re: None

Thursday, 10/19/2017 6:25:03 PM

Thursday, October 19, 2017 6:25:03 PM

Post# of 251544
(RVNC) - Allergan's stock-price struggles sure to trigger breakup questions: analyst

http://www.fiercepharma.com/pharma/shares-struggling-allergan-should-expect-breakup-spotlight-analyst


Bernstein analyst Ronny Gal echoed those sentiments in his own note to clients. “[W]e continue to believe the company’s aesthetic business is worth close to the complete value of the stock.”


Allergan maybe better off as a pure aesthetic's play.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up